EPT Disclosure

14 Jun 2006 11:15

Deutsche Bank AG London14 June 2006 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Deutsche Bank AG London Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the Ordinarydealings being disclosed relate (Note 1) Date of dealing 13/06/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 25,200 £13.075 £13.07 Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)e.g. CFD CFD Long 25,000 £13.07CFD Long 200 £13.075 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American, Date paid/received pere.g. call option varying etc. relates (Note 5) price European etc. unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. NONE Date of disclosure 14/06/2006 Contact name Kelly-Jade Ledwich Telephone number 020 7545 7804 Name of offeree/offeror with which connected AstraZeneca Plc Nature of connection (Note 6) Adviser to the offeror Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange